MARKET

MYOS

MYOS

MYOS RENS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.480
+0.030
+2.07%
Closed 16:00 09/18 EDT
OPEN
1.490
PREV CLOSE
1.450
HIGH
1.490
LOW
1.435
VOLUME
47.35K
TURNOVER
--
52 WEEK HIGH
3.850
52 WEEK LOW
0.7412
MARKET CAP
17.53M
P/E (TTM)
-3.8312
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average MYOS stock price target is 3.750 with a high estimate of 3.750 and a low estimate of 3.750.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About MYOS
MYOS RENS Technology Inc. is focused on the discovery, development and commercialization of nutritional ingredients, functional foods, and other technologies for maintaining or improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle-related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement that has been shown in clinical studies to temporarily decrease the levels of serum myostatin, MYO-T12, a formulation containing Fortetropin. Fortetropin is the Company’s all-natural food ingredient clinically shown to enhance muscle size, lean body mass and strength as part of resistance training in humans. Fortetropin is made from fertilized chicken egg yolks using a process that retains the biological integrity and bioactivity of the product.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of MYOS RENS Technology Inc stock information, including NASDAQ:MYOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYOS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MYOS stock methods without spending real money on the virtual paper trading platform.